Z-0534-2026 Class II Ongoing

Recalled by Quest International, Inc. — Doral, FL

FDA device recall Z-0534-2026 was initiated by Quest International, Inc. on Oct 1, 2025 and is designated Class II. Reason for recall: Due to distributing the measles IgG IVD without a premarket approved/cleared. The recall status is ongoing.

Recall details

Product Type
Devices
Report Date
Nov 26, 2025
Initiation Date
Oct 1, 2025
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Brand Name: ReQuest Measles IgG Product Name: Rubeola IgG Enzyme Linked Immunoabsorbant Assay Model/Catalog Number: 01-190 Software Version: N/A Product Description: Measles IgG tests, performed using ELISA (Enzyme-Linked Immunosorbent Assay) method, used to detect the presence of IgG antibodies against measles virus in a patient's serum or plasma Component: not a component

Reason for recall

Due to distributing the measles IgG IVD without a premarket approved/cleared.

Distribution pattern

All products were distributed in the United States. (Utah, Washington).

Code information

Lot Code: DI# 00850487007357 Lots affected: L07024 and E03025

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0534-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0534-2026. Report a data issue: hello@regdatalab.com.